TOKYO — U.S.-based GE HealthCare Technologies has expanded its reach in Japan while wielding market-leading computed tomography (CT) scanners as well as diagnostic drugs, pushing local players Canon and Fujifilm Holdings to try to counter its substantially larger scale.
GE HealthCare entered the field of surgical treatment with an acquisition in 2021 and was spun off from General Electric in January 2023. The company looks to expand further through the highly profitable diagnostic drug business — radiopharmaceuticals in particular. Radioactive substances can be used to diagnose cancer and Alzheimer’s disease as well as aid in providing treatment tailored to each patient.
